A detailed history of Van Eck Associates Corp transactions in Pfizer Inc stock. As of the latest transaction made, Van Eck Associates Corp holds 16,560,256 shares of PFE stock, worth $428 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
16,560,256
Previous 16,104,088 2.83%
Holding current value
$428 Million
Previous $451 Million 6.07%
% of portfolio
0.6%
Previous 0.64%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$27.7 - $31.39 $12.6 Million - $14.3 Million
456,168 Added 2.83%
16,560,256 $478 Million
Q2 2024

Jul 31, 2024

BUY
$25.26 - $29.6 $7.34 Million - $8.61 Million
290,760 Added 1.84%
16,104,088 $451 Million
Q1 2024

Apr 30, 2024

BUY
$25.89 - $29.73 $73.2 Million - $84.1 Million
2,829,178 Added 21.79%
15,813,328 $439 Million
Q4 2023

Feb 05, 2024

BUY
$26.13 - $33.94 $85.3 Million - $111 Million
3,265,276 Added 33.6%
12,984,150 $374 Million
Q3 2023

Nov 08, 2023

BUY
$32.09 - $37.51 $72.9 Million - $85.3 Million
2,273,275 Added 30.53%
9,718,874 $322 Million
Q2 2023

Aug 03, 2023

BUY
$36.12 - $41.79 $130 Million - $151 Million
3,601,529 Added 93.69%
7,445,599 $273 Million
Q1 2023

May 03, 2023

BUY
$39.39 - $51.28 $91.7 Million - $119 Million
2,326,950 Added 153.38%
3,844,070 $157 Million
Q4 2022

Feb 08, 2023

BUY
$41.75 - $54.5 $44,338 - $57,879
1,062 Added 0.07%
1,517,120 $77.7 Million
Q3 2022

Oct 27, 2022

BUY
$43.76 - $53.42 $9.1 Million - $11.1 Million
207,989 Added 15.9%
1,516,058 $66.3 Million
Q2 2022

Aug 03, 2022

BUY
$46.53 - $55.17 $39.7 Million - $47 Million
852,451 Added 187.1%
1,308,069 $68.6 Million
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $1.44 Million - $1.78 Million
-31,474 Reduced 6.46%
455,618 $23.6 Million
Q4 2021

Jan 26, 2022

SELL
$41.32 - $61.25 $102 Million - $152 Million
-2,476,151 Reduced 83.56%
487,092 $28.8 Million
Q3 2021

Nov 03, 2021

SELL
$39.25 - $50.42 $73.7 Million - $94.7 Million
-1,878,344 Reduced 38.8%
2,963,243 $127 Million
Q2 2021

Aug 10, 2021

BUY
$35.91 - $40.68 $6.28 Million - $7.11 Million
174,809 Added 3.75%
4,841,587 $190 Million
Q1 2021

May 13, 2021

BUY
$33.49 - $37.77 $41.9 Million - $47.3 Million
1,251,532 Added 36.65%
4,666,778 $169 Million
Q4 2020

Feb 09, 2021

BUY
$33.47 - $42.56 $1.36 Million - $1.73 Million
40,676 Added 1.21%
3,415,246 $126 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $5.62 Million - $6.59 Million
176,988 Added 5.54%
3,374,570 $124 Million
Q2 2020

Aug 10, 2020

BUY
$30.12 - $36.54 $10.9 Million - $13.2 Million
360,262 Added 12.7%
3,197,582 $105 Million
Q1 2020

May 12, 2020

BUY
$27.03 - $38.62 $2.38 Million - $3.4 Million
88,099 Added 3.2%
2,837,320 $92.6 Million
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $53.9 Million - $61.2 Million
1,638,466 Added 147.51%
2,749,221 $108 Million
Q3 2019

Nov 08, 2019

BUY
$32.49 - $42.13 $7.09 Million - $9.19 Million
218,235 Added 24.45%
1,110,755 $39.9 Million
Q2 2019

Aug 07, 2019

BUY
$36.98 - $41.52 $277,904 - $312,022
7,515 Added 0.85%
892,520 $38.7 Million
Q1 2019

May 13, 2019

SELL
$37.5 - $41.2 $2.68 Million - $2.94 Million
-71,378 Reduced 7.46%
885,005 $37.6 Million
Q4 2018

Feb 12, 2019

SELL
$38.47 - $43.86 $19.1 Million - $21.8 Million
-496,151 Reduced 34.16%
956,383 $41.7 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $1.68 Million - $2.03 Million
-48,621 Reduced 3.24%
1,452,534 $64 Million
Q2 2018

Aug 13, 2018

BUY
$32.98 - $35.16 $5.33 Million - $5.68 Million
161,589 Added 12.06%
1,501,155 $54.5 Million
Q1 2018

May 11, 2018

BUY
$31.91 - $37.02 $1.22 Million - $1.41 Million
38,198 Added 2.94%
1,339,566 $47.5 Million
Q4 2017

Feb 12, 2018

SELL
$33.26 - $35.29 $1.96 Million - $2.08 Million
-58,889 Reduced 4.33%
1,301,368 $47.1 Million
Q3 2017

Nov 09, 2017

BUY
$31.0 - $34.15 $14.3 Million - $15.7 Million
460,062 Added 51.11%
1,360,257 $48.6 Million
Q2 2017

Aug 11, 2017

BUY
N/A
900,195
900,195 $30.2 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.